| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.16B | +4.3% |
| Gross profit | ¥0.07B | — |
| Operating income | ¥0.01B | — |
| Net income | ¥0.01B | -20.1% |
| Gross margin | 42.6% | Net margin 7.6% |
| Revenue Q/Q | +7.5% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.09B | 57.4% |
| R&D | ¥0.01B | 4.3% |
| SG&A | ¥0.04B | 27.5% |
| Tax & other | ¥0.00B | 0.9% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
康华生物 ・ 帝科股份 ・ 胜蓝股份 ・ 山水比德 ・ 捷安高科 ・ 首都在线 ・ 中船汉光 ・ 美瑞新材 ・ 锦盛新材 ・ 新强联 ・ 交大思诺 ・ 四会富仕
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies